DRUG · Mapped RxNorm record
Rosuvastatin
Normalized identity: rosuvastatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)
NCT04542382
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Rosuvastatin (Inhibitor arm)
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Eltrombopag
Normalized identity: eltrombopagView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedIdentification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Healthy Volunteersunresolved
Interventions
RosuvastatinDRUG · verified · RxNorm: rosuvastatin
EltrombopagDRUG · verified · RxNorm: eltrombopag
Sponsors & collaborators
University of California, San Franciscolead sponsor
Food and Drug Administration (FDA)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04542382 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.